Pharmacokinetics of Melatonin in Preterm Infants

被引:0
|
作者
N Merchant
D Azzopardi
D Edwards
机构
[1] Neonatology,
[2] Imperial College London,undefined
[3] MRC Centre for Clinical Sciences,undefined
来源
Pediatric Research | 2011年 / 70卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Background: There is strong experimental evidence of a neuroprotective effect of melatonin in immature animals. However, pharmacokinetic (PK) data on melatonin in preterm infants is lacking. The aim was to examine the preterm pharmacokinetic profile.
引用
收藏
页码:681 / 681
相关论文
共 50 条
  • [21] Population pharmacokinetics of fentanyl in very preterm infants
    Bardol, Maddlie
    Fellman, Vineta
    Norman, Elisabeth
    Standing, Joseph
    PEDIATRIC RESEARCH, 2021, 90 (SUPPL 1) : 35 - 36
  • [22] Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants
    Clegg, Lindsay
    Freshwater, Ed
    Leach, Amanda
    Villafana, Tonya
    Hamren, Ulrika Waehlby
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (05): : 555 - 567
  • [23] PHARMACOKINETICS OF ORAL AND INTRAVENOUS INDOMETHACIN IN PRETERM INFANTS
    BHAT, R
    VIDYASAGAR, D
    FISHER, E
    HASTREITER, A
    RAMIREZ, JL
    BURNS, L
    EVANS, M
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1980, 1 (2-3): : 101 - 110
  • [24] Oral pharmacokinetics of doxapram in preterm infants.
    de Wildt, SN
    Sie, SD
    Dullemond, RC
    Vulto, AP
    van den Anker, JN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P68 - P68
  • [25] VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS
    JAMES, A
    KOREN, G
    MILLIKEN, J
    SOLDIN, S
    PROBER, CG
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A89 - A89
  • [26] EFFECTS OF INDOMETHACIN ON DIGOXIN PHARMACOKINETICS IN PRETERM INFANTS
    KOREN, G
    ZARFIN, Y
    PERLMAN, M
    MACLEOD, SM
    PEDIATRIC PHARMACOLOGY, 1984, 4 (01): : 25 - 30
  • [27] MATURATIONAL CHANGES OF THEOPHYLLINE PHARMACOKINETICS IN PRETERM INFANTS
    DOTHEY, CI
    TSERNG, KY
    KAW, S
    KING, KC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) : 461 - 468
  • [28] VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS
    JAMES, A
    KOREN, G
    MILLIKEN, J
    SOLDIN, S
    PROBER, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 52 - 54
  • [29] Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants
    Gonzalez, Daniel
    Delmore, Paula
    Bloom, Barry T.
    Cotten, C. Michael
    Poindexter, Brenda B.
    McGowan, Elisabeth
    Shattuck, Karen
    Bradford, Kathleen K.
    Smith, P. Brian
    Cohen-Wolkowiez, Michael
    Morris, Maurine
    Yin, Wanrong
    Benjamin, Daniel K., Jr.
    Laughon, Matthew M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 2888 - 2894
  • [30] Pharmacokinetics and metabolism of intravenous midazolam in preterm infants
    de Wildt, SN
    Kearns, GL
    Hop, WCJ
    Murry, DJ
    Abdel-Rahman, SM
    van den Anker, JN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (06) : 525 - 531